4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-26-285505
Chief Financial Officer sold 2,362 shares at $20.37 ($48,114)
From the SEC's structured data for this filing
Trades in this filing
Lucera Erick · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-25 | Sale : show line 1 in the form | −2,362 | $20.37 | $48,114 | 121,563 | D |
| Open-market sales · 2,362 sh · avg $20.37 · $48,114 | ||||||
Loading xslF345X06/ownership.xml…